Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Higinia R. Cardenes, MD, PhD
Indiana University
Study Chair - Howard D. Homesley, MD
Gynecologic Oncology Network
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- Stanford Cancer Center at Stanford University Medical Center
Stanford, California, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Ccop - Northern Indiana Cr Consortium
South Bend, Indiana, United States
- Ccop - Ochsner
New Orleans, Louisiana, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
- Tufts - New England Medical Center
Boston, Massachusetts, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- Ccop - Southern Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
- Norris Cotton Cancer Center at Dartmouth Medical School
Lebanon, New Hampshire, United States
- Mbccop-Our Lady of Mercy Cancer Center
The Bronx, New York, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Ccop - Geisinger Clinic and Medical Center
Danville, Pennsylvania, United States
- Abramson Cancer Center at University of Pennsylvania Medical Center
Philadelphia, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Ccop - Scott and White Hospital
Temple, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 1997
- Primary completion
- 28 Feb 2007
- Completion
- —
- Last update posted
- 9 Jul 2013
- Registered enrollment
- 166
- Registry id
- NCT00003128
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.